1. Home
  2. CGEN vs IH Comparison

CGEN vs IH Comparison

Compare CGEN & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$1.65

Market Cap

125.3M

Sector

Health Care

ML Signal

HOLD

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$2.51

Market Cap

129.4M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGEN
IH
Founded
1993
1996
Country
Israel
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
125.3M
129.4M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
CGEN
IH
Price
$1.65
$2.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
271.2K
10.8K
Earning Date
11-10-2025
12-26-2025
Dividend Yield
N/A
3.40%
EPS Growth
N/A
N/A
EPS
N/A
0.29
Revenue
$6,903,000.00
$123,215,612.00
Revenue This Year
N/A
$39.02
Revenue Next Year
$231.15
N/A
P/E Ratio
N/A
$8.81
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$1.55
52 Week High
$2.66
$3.60

Technical Indicators

Market Signals
Indicator
CGEN
IH
Relative Strength Index (RSI) 53.50 36.37
Support Level $1.47 $2.66
Resistance Level $1.61 $2.74
Average True Range (ATR) 0.09 0.16
MACD 0.01 -0.03
Stochastic Oscillator 72.03 16.95

Price Performance

Historical Comparison
CGEN
IH

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

Share on Social Networks: